Disease data source information

Primary source:

Background sources and references:

• Akahira, J. I., et al. "Expression of EBAG9/RCAS1 Is Associated with Advanced Disease in Human Epithelial Ovarian Cancer." British Journal of Cancer 90, no. 11 (2004): doi:10.1038/sj.bjc.6601832. »
• Amacher, D. E. "Serum Transaminase Elevations as Indicators of Hepatic Injury Following the Administration of Drugs." Regulatory Toxicology and Pharmacology 27, no. 2 (1998): doi:10.1006/rtph.1998.1201. »
• Amacher, D. E., et al. "Use of Proteomic Methods to Identify Serum Biomarkers Associated with Rat Liver Toxicity or Hypertrophy." Clinical Chemistry 51, no. 10 (2005): doi:10.1373/clinchem.2005.049908. »
• Anton, R. C., et al. "Absence of Prognostic Significance of BCL-2 Immunopositivity in Non-Small Cell Lung Cancer: Analysis of 427 Cases." Human Pathology 28, no. 9 (1997): 1079-1082.
• Anton, R. C., et al. "The Expression of Cyclins D1 and E in Predicting Short-Term Survival in Squamous Cell Carcinoma of the Lung." Modern Pathology 13, no. 11 (2000): 1167–1172.
• Antonangelo, L., et al. "Morphometric Evaluation of Argyrophilic Nucleolar Organizer Region Is Useful in Predicting Long-Term Survival in Squamous Cell Carcinoma of the Lung." Chest 111, no. 1 (1997): doi:10.1378/chest.111.1.110. »
• Ashamiss, F., et al. "Clinical Significance of Arginase after Liver Transplantation." Annals of Transplantation 9, no. 3 (2004): 58-60.
• Au, N. H., et al. "P63 Expression in Lung Carcinoma: A Tissue Microarray Study of 408 Cases." Applied Immunohistochemistry & Molecular Morphology 12, no. 3 (2004): 240-247.
• Banerjee, S., et al. "Epidermal Growth Factor Induces WISP-2/CCN5 Expression in Estrogen Receptor-Alpha-Positive Breast Tumor Cells through Multiple Molecular Cross-Talks." Molecular Cancer Research 3, no. 3 (2005): 151-162.
• Behrens, P., U. Brinkmann, and A. Wellmann. "CSE1L/CAS: Its Role in Proliferation and Apoptosis." Apoptosis 8, no. 1 (2003): 39-44.
• Beliakoff, J. and L. Whitesell. "Hsp90: An Emerging Target for Breast Cancer Therapy." Anti-Cancer Drugs 15, no. 7 (2004): 651-662.
• Berclaz, G., et al. "EGFR Dependent Expression of STAT3 (but Not STAT1) in Breast Cancer." International Journal of Oncology 19, no. 6 (2001): 1155-1160.
• Bermont, L., et al. "Relevance of p185 HER-2/neu Oncoprotein Quantification in Human Primary Breast Carcinoma." Breast Cancer Research and Treatment 63, no. 2 (2000): 163-169.
• Berois, N., et al. "Detection of Bone Marrow-Disseminated Breast Cancer Cells Using an RT-PCR Assay of MUC5B mRNA." International Journal of Cancer 103, no. 4 (2003): 550-555.
• Berstein, L. M., et al. "Aromatase (CYP19) Expression in Tumor-Infiltrating Lymphocytes and Blood Mononuclears." Journal of Cancer Research and Clinical Oncology 128, no. 3 (2002): 173-176.
• Blok, R., et al. "Analysis of Prognostic Factors for the Extent of Vascularity of Serous Ovarian Cancer on the Basis of CD34 Antigen Expression." Ginekologia Polska 75, no. 2 (2004): 91-98.
• Bolli, M., et al. "Tissue Microarray Evaluation of Melanoma Antigen E (MAGE) Tumor-Associated Antigen Expression: Potential Indications for Specific Immunotherapy and Prognostic Relevance in Squamous Cell Lung Carcinoma." Annals of Surgery 236, no. 6 (2002): 785-793.
• Bonné, A. C. M., et al. "Chromosome 3 Translocations and Familial Renal Cell Cancer." Current Molecular Medicine 4, no. 8 (2004): 849-854.
• Bosma, A. J., et al. "Detection of Circulating Breast Tumor Cells by Differential Expression of Marker Genes." Clinical Cancer Research 8, no. 6 (2002): 1871-1877.
• Brown, L., et al. "Amplification of EMSY, a Novel Oncogene on 11q13, in High Grade Ovarian Surface Epithelial Carcinomas." Gynecologic Oncology 100, no. 2 (2006): doi:10.1016/j.ygyno.2005.08.026. »
• Burt, C. W. and E. Hing. "Making Patient-Level Estimates from Medical Encounter Records Using a Multiplicity Estimator." Statistics in Medicine 26, no. 8 (2007): 1762-1774.
• Carbognani, P., et al. "Expression of Human CD44v6 in Non-Small-Cell Lung Cancer." European Surgical Research 30, no. 6 (1998): doi:10.1159/000008605. »
• Casali, C., et al. "The Prognostic Role of C-Kit Protein Expression in Resected Large Cell Neuroendocrine Carcinoma of the Lung. Commentary." The Annals of Thoracic Surgery 77, no. 1 (2004): 247-253.
• Castro, C. Y., et al. "Prognostic Implications Of Calbindin-D28k Expression in Lung Cancer: Analysis of 452 Cases." Modern Pathology 13, no. 7 (2000): 808–813.
• Centers for Disease Control and Prevention. "NAMCS/NHAMCS—Questionnaires, Datasets, and Related Documentation." »
• Chen, Y. J., et al. "Overexpression of Dihydrodiol Dehydrogenase Is Associated with Cisplatin-Based Chemotherapy Resistance in Ovarian Cancer Patients." Gynecologic Oncology 97, no. 1 (2005): 110-117.
• Chen, Y. T., et al. "Messenger RNA Expression Ratios among Four Genes Predict Subtypes of Renal Cell Carcinoma and Distinguish Oncocytoma from Carcinoma." Clinical Cancer Research 11, no. 18 (2005): 6558-6566.
• Chu, J.-S., J.-Y. Sheiv, and C.-S. Huang. "Immunohistochemical Analysis of Survivin Expression in Primary Breast Cancers." Journal of the Formosan Medical Association 103, no. 12 (2004): 925-931.
• Chuang, S. T., et al. "Overexpression of Glutathione S-Transferase Alpha in Clear Cell Renal Cell Carcinoma." American Journal of Clinical Pathology 123, no. 3 (2005): 421-429.
• Ciardiello, F. and G. Tortora. "Interactions between the Epidermal Growth Factor Receptor and Type I Protein Kinase A: Biological Significance and Therapeutic Implications." Clinical Cancer Research 4, no. 4 (1998): 821-828.
• Cohen, R., et al. "The Prognostic Application of Cytokeratin Typing of Nonsmall Cell Lung Carcinoma: A Retrospective Study." Cancer 79, no. 3 (1997): 468-473.
• Conticello, C., et al. "IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins." Journal of Immunology 172, no. 9 (2004): 5467-5477.
• Costa, L. G., T. B. Cole, and C. E. Furlong. "Gene-Environment Interactions: Paraoxonase (PON1) and Sensitivity to Organophosphate Toxicity." Laboratory Medicine 37, no. 2 (2006): 109-114.
• Coventry, B. J., et al. "Lack of IL-2 Cytokine Expression Despite Il-2 Messenger RNA Transcription in Tumor-Infiltrating Lymphocytes in Primary Human Breast Carcinoma: Selective Expression of Early Activation Markers." The Journal of Immunology 156, no. 9 (1996): 3486-3492.
• Cui, D., et al. "Characterization of BRCAA1 and Its Novel Antigen Epitope Identification." Cancer Epidemiology, Biomarkers & Prevention 13, no. 7 (2004): 1136-1145.
• D'Souza, T., R. Agarwal, and P. J. Morin. "Phosphorylation of Claudin-3 at Threonine 192 by cAMP-Dependent Protein Kinase Regulates Tight Junction Barrier Function in Ovarian Cancer Cells." The Journal of Biological Chemistry 280, no. 28 (2005): doi:10.1074/jbc.M502003200. »
• Darai, E., et al. "CD31 Expression in Benign, Borderline, and Malignant Epithelial Ovarian Tumors: An Immunohistochemical and Serological Analysis." Gynecologic Oncology 71, no. 1 (1998): 122-127.
• de Cremoux, P., et al. "Detection of MUC1-Expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction." Clinical Cancer Research 6, no. 8 (2000): 3117-3122.
• Deeb, G., et al. "Altered E-Cadherin and Epidermal Growth Factor Receptor Expressions Are Associated with Patient Survival in Lung Cancer: A Study Utilizing High-Density Tissue Microarray and Immunohistochemistry." Modern Pathology 17, no 4 (2004): doi:10.1038/modpathol.3800041. »
• deGraffenried, L. A., et al. "Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells with Aberrant Akt Activity." Clinical Cancer Research 10, no. 23 (2004): 8059-8067.
• Di Nunno, L., et al. "Estrogen and Progesterone Receptors in Non-Small Cell Lung Cancer in 248 Consecutive Patients who Underwent Surgical Resection." Archives of Pathology & Laboratory Medicine 124, no. 10 (2000): 1467-1470.
• Diefenbach, C. S. M., et al. "Preoperative Serum YKL-40 Is a Marker for Detection and Prognosis of Endometrial Cancer." Gynecologic Oncology 104, no. 2 (2007): doi:10.1016/j.ygyno.2006.08.028. »
• Downey, R. J., et al. "Large Cell Carcinoma of the Lung: Results of Resection for a Cure." The Journal of Thoracic and Cardiovascular Surgery 117, no. 3 (1999): 599-604.
• Du, H., et al. "Hypericin-Mediated Photodynamic Therapy Elicits Differential Interleukin-6 Response in Nasopharyngeal Cancer." Cancer Letters 235, no. 2 (2006): 202-208.
• Dufour, D. R., et al. "Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring." Clinical Chemistry 46, no. 12 (2000): 2050-2068.
• Dulaimi, E., et al. "Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients." Clinical Cancer Research 10, no. 18 (2004): doi:10.1158/1078-0432.CCR-04-0597. »
• Ebert, M. P., et al. "Overexpression of Cathepsin B in Gastric Cancer Identified by Proteome Analysis." Proteomics 5, no. 6 (2005): 1693-1704.
• Ellis, M. J., et al. "Insulin-Like Growth Factors in Human Breast Cancer." Breast Cancer Research and Treatment 52, no. 1-3 (1998): 175-184.
• Faried, A., et al. "Expression of Heat-Shock Protein Hsp60 Correlated with the Apoptotic Index and Patient Prognosis in Human Oesophageal Squamous Cell Carcinoma." European Journal of Cancer 40, no. 18 (2004): 2804-2811.
• Felton, T., et al. "Identification of Carcinoma Cells in Peripheral Blood Samples of Patients with Advanced Breast Carcinoma Using RT-PCR Amplification of CK7 and MUC1." The Breast 13, no. 1 (2004): doi:10.1016/S0960-9776(03)00126-7. »
• Ferguson, R. E., et al. "Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I Beta-Tubulin Gene but Changes in Tubulin Isotype Protein Expression." Clinical Cancer Research 11, no. 9 (2005): 3439-3445.
• Ferrandina, G., et al. "Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients." Clinical Cancer Research 12, no. 9 (2006): doi:10.1158/1078-0432.CCR-05-2715. »
• Ford, D., et al. "Risks of Cancer in BRCA1-Mutation Carriers. Breast Cancer Linkage Consortium." Lancet 343, no. 8899 (1994): 692-695.
• Foster, G. R., R. D. Goldin, and D. B. Oliveira. "Serum F Protein: A New Sensitive and Specific Test of Hepatocellular Damage." Clinica Chimica Acta 184, no. 1 (1989): 85-92.
• Friederichs, J., et al. "Prognostic Impact of CK-20-Positive Cells in Peripheral Venous Blood of Patients with Gastrointestinal Carcinoma." World Journal of Surgery 29, no. 4 (2005): 422-428.
• Fujita, S., et al. "NY-ESO-1 Expression and Immunogenicity in Esophageal Cancer." Clinical Cancer Research 10, no. 19 (2004): doi:10.1158/1078-0432.CCR-04-0819. »
• Fukushima, M., et al. "Elastosis in Lung Carcinoma: Immunohistochemical, Ultrastructural and Clinical Studies." Pathology International 50, no. 8 (2000): 10.1046/j.1440-1827.2000.01103.x. »
• Gadducci, A., et al. "Serum Tumor Markers in the Management of Ovarian, Endometrial and Cervical Cancer: Ovarian and Prostate Cancers." Biomedicine & Pharmacotherapy 58, no. 1 (2004): 24-38.
• Garcia-Tuñón, I., et al. "IL-6, Its Receptors and Its Relationship with BCL-2 and Bax Proteins in Infiltrating and In Situ Human Breast Carcinoma." Histopathology 47, no. 1 (2005): 82-89.
• Giffen, P. S., et al. "Alpha-Glutathione S-Transferase in the Assessment of Hepatotoxicity—Its Diagnostic Utility in Comparison with Other Recognized Markers in the Wistar Han Rat." Toxicologic Pathology 30, no. 3 (2002): 365-372.
• Grebenchtchikov, N., et al. "Development of an ELISA for Measurement of BCARI Protein in Human Breast Cancer Tissue." Clinical Chemistry 50, no. 8 (2004): 1356-1363.
• Gresh, L., et al. "A Transcriptional Network in Polycystic Kidney Disease." The EMBO Journal 23, no. 7 (2004): 1657-1668.
• Grigoriev, M. Y., et al. "Tissue Transglutaminase Expression in Breast Carcinomas." Journal of Experimental & Clinical Cancer Research 20, no. 2 (2001): 265-268.
• Grünewald, K., et al. "Mammaglobin Gene Expression: A Superior Marker of Breast Cancer Cells in Peripheral Blood in Comparison to Epidermal-Growth-Factor Receptor and Cytokeratin-19." Laboratory Investigation 80, no. 7 (2000): 1071-1077.
• Guo, H. F., et al. "Somatic Mutations of VHL Gene and HIF-1alpha Expression in Primary Renal Clear Cell Carcinomas." Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery] 42, no. 4 (2004): 196-200.
• Hampton, R., et al. "Differential Expression of Carcinoembryonic Antigen (CEA) Splice Variants in Whole Blood of Colon Cancer Patients and Healthy Volunteers: Implication for the Detection of Circulating Colon Cancer Cells." Oncogene 21, no. 51 (2002): 7817-7823.
• Han, W. K., et al. "Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell Carcinoma." Journal of the American Society of Nephrology 16, no. 4 (2005): 1126-1134.
• Hasegawa, K., et al. "A-Kinase Anchoring Protein 3 Messenger RNA Expression in Ovarian Cancer and Its Implication on Prognosis." International Journal of Cancer 108, no. 1 (2003): doi:10.1002/ijc.11565. »
• Hata, K., et al. "Expression of Angiopoietin-1, Angiopoietin-2, and Tie2 Genes in Normal Ovary with Corpus Luteum and in Ovarian Cancer." Oncology 62, no. 4 (2002): doi:10.1159/000065066. »
• Heinzelmann-Schwarz, V. A., et al. "Overexpression of the Cell Adhesion Molecules DDR1, Claudin 3, and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer." Clinical Cancer Research 10, no. 13 (2004): doi:10.1158/1078-0432.CCR-04-0073. »
• Herrem, C. J., et al. "Expression of EphA2 Is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma." Clinical Cancer Research 11, no. 1 (2005): 226-231.
• Hes, O., et al. "Clear Cell Type of Renal Cell Carcinoma with Numerous Hyaline Globules: A Diagnostic Pitfall." Pathology International 55, no. 3 (2005): 150-154.
• Hibbs, K., et al. "Differential Gene Expression in Ovarian Carcinoma: Identification of Potential Biomarkers." American Journal of Pathology 165, no. 2 (2004): 397-414.
• Hirai, K., et al. "Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer." The Annals of Thoracic Surgery 79, no. 1 (2005): doi:10.1016/j.athoracsur.2004.06.118. »
• Hiramatsu, K., et al. "N¹, N¹²-Diacetylspermine as a Sensitive and Specific Novel Marker for Early- and Late-Stage Colorectal and Breast Cancers." Clinical Cancer Research 11, no. 8 (2005): 2986-2990.
• Hiroshima, K., et al. "Alpha-Fetoprotein-Producing Lung Carcinoma: Report of Three Cases." Pathology International 52, no. 1 (2002): doi:10.1046/j.1440-1827.2002.01311.x. »
• Hoefele, J., et al. "Clinical and Histological Presentation of 3 Siblings with Mutations in the NPHP4 Gene." American Journal of Kidney Diseases 43, no. 2 (2004): 358-364.
• Hoffmann, R. and A. Valencia. "A Gene Network for Navigating the Literature." Information Hyperlinked Over Proteins. »
• Hoon, D. S. B., et al. "Detection of Metastatic Breast Cancer by Beta-hCG Polymerase Chain Reaction." International Journal of Cancer 69, no. 5 (1998): doi:10.1002/(SICI)1097-0215(19961021)69:5<369::AID-IJC3>3.0.CO;2-3. »
• Howard, J. M. "Possible, New Support of My Explanation of Breast Cancer." Anthropogeny.com. »
• Huang, J., et al. "Prognostic Significance of Glutathione S-Transferase-Pi in Invasive Breast Cancer." Modern Pathology 16, no. 6 (2003): 558-565.
• Huang, X., et al. "Co-Expression of Y Box-Binding Protein-1 and P-Glycoprotein as a Prognostic Marker for Survival in Epithelial Ovarian Cancer." Gynecologic Oncology 93, no. 2 (2004): doi:10.1016/j.ygyno.2004.01.040. »
• Huddleston, H. G., et al. "Clinical Applications of Microarray Technology: Creatine Kinase B Is an Up-Regulated Gene in Epithelial Ovarian Cancer and Shows Promise as a Serum Marker." Gynecologic Oncology 96, no. 1 (2005): 77-83.
• Ioachim, E., et al. "Clinicopathological Study of the Expression of HSP27, pS2, Cathepsin D and Metallothionein in Primary Invasive Breast Cancer." The Breast 12, no. 2 (2003): doi:10.1016/S0960-9776(02)00290-4. »
• Isonishi, S. "Biomarker in Gynecologic Malignancies." Gan To Kagaku Ryoho. [Cancer and Chemotherapy] 13, no. 7 (2004): 1003-1007.
• Iyoda, A., et al. "Pulmonary Large Cell Carcinomas with Neuroendocrine Features Are High-Grade Neuroendocrine Tumors." The Annals of Thoracic Surgery 73, no. 4 (2002): 1049-1054.
• Izumi, M., et al. "Expression of Tumor-Associated Antigen RCAS1 Correlates Significantly with Poor Prognosis in Nonsmall Cell Lung Carcinoma." Cancer 92, no. 2 (2001): 446-451.
• Johansson, L. "Histopathologic Classification of Lung Cancer: Relevance of Cytokeratin and TTF-1 Immunophenotyping." Annals of Diagnostic Pathology 8, no. 5 (2004): doi:10.1016/j.anndiagpath.2004.07.001. »
• Johnston, S. R., et al. "Integration of Signal Transduction Inhibitors with Endocrine Therapy: An Approach to Overcoming Hormone Resistance in Breast Cancer." Clinical Cancer Research 9, no. 1 (2003): 524S-532S.
• Kadota, A., et al. "Evaluation of Expression of CD15 and sCD15 in Non-Small Cell Lung Cancer." International Journal of Oncology 15, no. 6 (1999): 1081-1089.
• Kaganoi, J., et al. "Detection of Circulating Oesophageal Squamous Cancer Cells in Peripheral Blood and Its Impact on Prognosis." The British Journal of Surgery 91, no. 8 (2004): 1055-1060.
• Kamiya, N., et al. "Simultaneous Measurement of CA 125, CA 19-9, Tissue Polypeptide Antigen, and Immunosuppressive Acidic Protein to Predict Recurrence of Ovarian Cancer." Obstetrics & Gynecology 76, no. 3 (1990): 417-421.
• Kanczuga-Koda, L., et al. "Connexins 26 and 43 Correlate with Bak, but Not with BCL-2 Protein in Breast Cancer." Oncology Reports 14, no. 2 (2005): 325-329.
• Kardana, A., G. D. Braunstein, and L. A. Cole. "Gonadotropin β-Subunit Nicking Enzyme (GBNE), a Potential Marker of Early Malignancies." Oncology Research 8, no. 1 (1996): 13-16.
• Kawai, M. and S. Hosaki. "Clinical Usefulness of Malate Dehydrogenase and Its Mitochondrial Isoenzyme in Comparison with Aspartate Aminotransferase and Its Mitochondrial Isoenzyme in Sera of Patients with Liver Disease." Clinical Biochemistry 23, no. 4 (1990): 327-334.
• Kawai, T., S. Hiroi, and C. Torikata. "Expression in Lung Carcinomas of Platelet-Derived Growth Factor and Its Receptors." Laboratory Investigation 77, no. 5 (1997): 431-436.
• Kawai, T., et al. "KM195 as an Immunohistochemical Marker of Adenocarcinoma of the Lung." Lung Cancer 15, no. 1 (1996): doi:10.1016/0169-5002(96)00569-7. »
• Khayrollah, A. A., et al. "Serum Alcohol Dehydrogenase Activity in Liver Diseases." Annals of Clinical Biochemistry 19 (1982): 35-42.
• Kim, C. H., et al. "Genetic Instability of Microsatellite Sequences in Non-Small Cell Lung Cancers." Lung Cancer 21, no. 1 (1998): doi:10.1016/S0169-5002(98)00036-1.
• Klein, O., et al. "An Approach for High Sensitivity Detection of Breast Cancer by Analysis of Changes in Structure of the Cytoplasmic Matrix of Lymphocytes Specifically Induced by a Specific Breast Tumour Antigen (MUC-l/SEC)." The Breast 11, no. 2 (2002): 137-143.
• Koike, H., et al. "Comparison of Methylation-Specific Polymerase Chain Reaction (MSP) with Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) in Peripheral Blood of Gastric Cancer Patients." Journal of Surgical Oncology 87, no. 4 (2004): 182-186.
• Konda, R., et al. "Expression of Hepatocyte Growth Factor and Its Receptor C-Met in Acquired Renal Cystic Disease Associated with Renal Cell Carcinoma." The Journal of Urology 171, no. 6 (2004): 2166-2170.
• Korsching, E., et al. "Cytogenetic Alterations and Cytokeratin Expression Patterns in Breast Cancer: Integrating a New Model of Breast Differentiation into Cytogenetic Pathways of Breast Carcinogenesis." Laboratory Investigation 82, no. 11 (2002): 1525–1533.
• Krajewski, S., et al. "Analysis of Bax and BCL-2 Expression in p53-Immunopositive Breast Cancers." Clinical Cancer Research 3, no. 2 (1997): 199-208.
• Kumar, R., R. A. Wang, and R. Bagheri-Yarmand. "Emerging Roles of MTA Family Members in Human Cancers." Seminars in Oncology 30, supplement 17 (2003): 30-37.
• Kurahashi, T., et al. "Expression of the Secreted Form of Clusterin Protein in Renal Cell Carcinoma as a Predictor of Disease Extension." BJU International 96, no. 6 (2005): 895-899.
• Kuroda, N., et al. "Immunohistochemical Identification of Intracytoplasmic Lumens by Cytokeratin Typing May Differentiate Renal Oncocytomas from Chromophobe Renal Cell Carcinomas." Histology and Histopathology 19, no. 1 (2004): 23-28.
• Lam, J. S., et al. "Role of Molecular Markers in the Diagnosis and Therapy of Renal Cell Carcinoma." Urology 55, supplement 5 (2005): 1-9.
• Landberg, G., et al. "Downregulation of the Potential Suppressor Gene IGFBP-rP1 in Human Breast Cancer Is Associated with Inactivation of the Retinoblastoma Protein, Cyclin E Overexpression and Increased Proliferation in Estrogen Receptor Negative Tumors." Oncogene 20, no. 27 (2001): 3497-3505.
• Lawson, J. S., et al. "Elevated Expression of the Tumor Suppressing Protein p53 Is Associated with the Presence of Mouse Mammary Tumor-Like env Gene Sequences (MMTV-like) in Human Breast Cancer." Breast Cancer Research and Treatment 87, no. 1 (2004): doi:10.1023/B:BREA.0000041573.09142.00. »
• Lee, B. C., et al. "Microarray Analysis of Differentially Expressed Genes Associated with Human Ovarian Cancer." International Journal of Oncology 24, no. 4 (2004): 847-851.
• Lehtonen, S. T., et al. "Peroxiredoxins, a Novel Protein Family in Lung Cancer." International Journal of Cancer 111, no. 4 (2004): 514-521.
• Li, Y.-R., et al. "Human Telomerase Reverse Transcriptase Expression and Its Clinical Significance in Laryngeal Squamous Cell Carcinoma." Aca Oto-Laryngologica 125, no. 4 (2005): 409-414.
• Li, Z., et al. "Overexpression of Synuclein-Gamma in Pancreatic Adenocarcinoma." Cancer 101, no. 1 (2004): 58-65.
• Lindblom, P., et al. "Isoforms of Alanine Aminotransferases in Human Tissues and Serum—Differential Tissue Expression Using Novel Antibodies." Archives of Biochemistry and Biophysics 466, no. 1 (2007): 66-77.
• Lindgren, V. "Renal Tumor with Overlapping Distal Nephron Morphology and Karyotype." Archives of Pathology & Laboratory Medicine 128, no. 11 (2004): 1274-1278.
• Liu, W.-K., et al. "The Relationship between HPV16 and Expression of CD44v6, nm23H1 in Esophageal Squamous Cell Carcinoma." Archives of Virology 150, no. 5 (2005): 991-1001.
• Loaiza-Pérez, A. I., et al. "Sensitivity of Renal Cell Carcinoma to Aminoflavone: Role of CYP1A1." The Journal of Urology 171, no. 4 (2004): 1688-1697.
• López-Guerrero, J. A., et al. "Use of Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) for Carcinoembryonic Antigen, Cytokeratin 19, and Maspin in the Detection of Tumor Cells in Leukapheresis Products from Patients with Breast Cancer: Comparison with Immunocytochemistry." Journal of Hematotherapy 8, no. 1 (1999): 53-61.
• Lu, K. H., et al. "Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis." Clinical Cancer Research 10, no. 10 (2004): 3291-3300.
• Luo, R. C., et al. "Detection of Serum S100 Protein and Tissue Polypeptide-Specific Antigen for Diagnosis and Treatment of Breast Cancer." Di Yi Jun Yi Da Xue Xue Bao [Academic Journal of the First Medical College of PLA] 24, no. 1 (2004): 102-104.
• Ma, X. Y., et al. "Expression of Survivin in Ovarian Epithelial Carcinoma and Its Correlation with Expression of Fas and FasL." Ai zheng [Chinese Journal of Cancer] 23, no. 2 (2004): 173-176.
• Maranchie, J. K., et al. "Solid Renal Tumor Severity in von Hippel Lindau Disease Is Related to Germline Deletion Length and Location." Human Mutation 23, no. 1 (2004): 40-46.
• Markeeva, N., et al. "Expression of Beta-Defensin-2 in Human Gastric Tumors: A Pilot Study." Experimental Oncology 27, no. 2 (2005): 130-135.
• Marrogi, A. J., et al. "Study of Tumor Infiltrating Lymphocytes and Transforming Growth Factor-β as Prognostic Factors in Breast Carcinoma." International Journal of Cancer 74, no. 5 (1997): 492-501.
• Martínez, N., et al. "The Nuclear Pore Complex Protein Nup88 Is Overexpressed in Tumor Cells." Cancer Research 59, no. 21 (1999): 5408-5411.
• Mataki, Y., et al. "Carcinoembryonic Antigen Messenger RNA Expression Using Nested Reverse Transcription-PCR in the Peripheral Blood During Follow-Up Period of Patients who Underwent Curative Surgery for Biliary-Pancreatic Cancer: Longitudinal Analyses." Clinical Cancer Research 10, no. 11 (2004): 3807-3814.
• Matsuda, J., et al. "Significance of Metastasis Detected by Molecular Techniques in Sentinel Nodes of Patients with Gastrointestinal Cancer." Annals of Surgical Oncology 11, no. 3 (2004): 250S-254S.
• Matsuzaki, H., et al. "Plasma Bikunin as a Favorable Prognostic Factor in Ovarian Cancer." Journal of Clinical Oncology 23, no. 7 (2005): 1463-1472.
• Mazal, P. R., et al. "Expression of Aquaporins and PAX-2 Compared to CD10 and Cytokeratin 7 in Renal Neoplasms: A Tissue Microarray Study." Modern Pathology 18, no. 4 (2005): 535-540.
• McKeown, S. T., et al. "The Cytotoxic Effects of Human Neutrophil Peptide-1 (HNP1) and Lactoferrin on Oral Squamous Cell Carcinoma (OSCC) in Vitro." Oral Oncology 42, no. 7 (2006): 685-690.
• McLemore, M. R. and B. Aouizerat. "Introducing the MUC16 Gene: Implications for Prevention and Early Detection in Epithelial Ovarian Cancer." Biological Research for Nursing 6, no. 4 (2005): 262-267.
• Menendez, J. A., I. Mehmi, and R. Lupu. "Heregulin-Triggered Her-2/neu Signaling Enhances Nuclear Accumulation of p21WAF1/CIP1 and Protects Breast Cancer Cells from Cisplatin-Induced Genotoxic Damage." International Journal of Oncology 26, no. 3 (2005): 649-659.
• Milde-Langosch, K., et al. "Overexpression of the p16 Cell Cycle Inhibitor in Breast Cancer Is Associated with a More Malignant Phenotype." Breast Cancer Research and Treatment 67, no. 1 (2001): 61-70.
• Mita, M. M., A. Mita, and E. K. Rowinsky. "Mammalian Target of Rapamycin: A New Molecular Target for Breast Cancer." Clinical Breast Cancer 4, no. 2 (2003): 126-137.
• Mitsudomi, T., et al. "Loss of Heterozygosity at 3p in Non-Small Cell Lung Cancer and Its Prognostic Implication." Clinical Cancer Research 2, no. 7 (1996): 1185-1189.
• Miyazawa, J., et al. "Expression of Mesenchyme-Specific Gene HMGA2 in Squamous Cell Carcinomas of the Oral Cavity." Cancer Research 64, no. 6 (2004): 2024-2029.
• Moldvay, J., et al. "Predictive Survival Markers in Patients with Surgically Resected Non-Small Cell Lung Carcinoma." Clinical Cancer Research 6, no. 3 (2000): 1125-1134.
• Mori, K., et al. "Highly Specific Marker Genes for Detecting Minimal Gastric Cancer Cells in Cytology Negative Peritoneal Washings." Biochemical and Biophysical Research Communications 313, no. 4 (2004): doi:10.1016/j.bbrc.2003.12.025. »
• Morris, M. R., et al. "Tumor Suppressor Activity and Epigenetic Inactivation of Hepatocyte Growth Factor Activator Inhibitor Type 2/SPINT2 in Papillary and Clear Cell Renal Cell Carcinoma." Cancer Research 65, no. 11 (2005): 4598-4606.
• Nakamura, H., et al. "Expression Pattern of the Scaffold Protein IQGAP1 in Lung Cancer." Oncology Reports 13, no. 3 (2005): 427-431.
• Nakopoulou, L., et al. "Immunohistochemical Expression of Caspase-3 as an Adverse Indicator of the Clinical Outcome in Human Breast Cancer." Pathobiology 69, no. 5 (2001): doi:10.1159/000064337. »
• Nakopoulou, L., et al. "The Favourable Prognostic Value of Oestrogen Receptor Beta Immunohistochemical Expression in Breast Cancer." Journal of Clinical Pathology 57, no. 5 (2004): 523-528.
• Nathwani, R. A., et al. "Serum Alanine Aminotransferase in Skeletal Muscle Diseases." Hepatology 41, no. 2 (2005): 380-382.
• National Cancer Institute. "SEER Cancer Statistics." Surveillance Epidemiology and End Results. »
• NCBI. "HAP1 Huntingtin-Associated Protein 1 [Homo sapiens]—Gene Result." Entrez Gene. »
• Nguyen, V. N., et al. "CD44 and Its v6 Spliced Variant in Lung Carcinomas: Relation to NCAM, CEA, EMA and UP1 and Prognostic Significance." Neoplasma 47, no. 6 (2000): 400-408.
• Nhung, N. V., et al. "Cytokeratins and Lung Carcinomas." Ceskoslovenská Patologie 35, no. 3 (1999): 80-84.
• Nomori, H., et al. "Squamous Cell Carcinoma of the Lung Associated with Palmo-Plantar Hyperkeratosis." Nihon Kyōbu Shikkan Gakkai Zasshi [The Japanese Journal of Thoracic Diseases] 343, no. 8899 (1994): 692-695.
• O'Brien, P. J., et al. "Advantages of Glutamate Dehydrogenase as a Blood Biomarker of Acute Hepatic Injury in Rats." Laboratory Animals 36, no. 3 (2002): 313-321.
• Ogawa, Y., et al. "Evaluation of Serum KL-6, a Mucin-Like Glycoprotein, as a Tumor Marker for Breast Cancer." Clinical Cancer Research 6, no. 10 (2000): 4069-4072.
• Ohigashi, Y., et al. "Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer." Clinical Cancer Research 11, no. 8 (2005): doi:10.1158/1078-0432.CCR-04-1469. »
• Onn, A., et al. "Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer." Clinical Cancer Research 10, no. 1 (2004): 136-143.
• Oya, M., et al. "C-Jun Activation in Acquired Cystic Kidney Disease and Renal Cell Carcinoma." The Journal of Urology 174, no. 2 (2005): doi:10.1097/01.ju.0000164656.99251.77. »
• Ozer, J., et al. "The Current State of Serum Biomarkers of Hepatotoxicity." Toxicology 245, no. 3 (2008): 194-205.
• Pan, C.-C., P. C.-H. Chen, and D. M.-T. Ho. "The Diagnostic Utility of MOC31, BerEP4, RCC Marker and CD10 in the Classification of Renal Cell Carcinoma and Renal Oncocytoma: An Immunohistochemical Analysis of 328 Cases." Histopathology 45, no. 5 (2004): doi:10.1111/j.1365-2559.2004.01962.x. »
• Pan, C.-C., P. C.-H. Chen, and H. Chiang. "Overexpression of KIT (CD117) in Chromophobe Renal Cell Carcinoma and Renal Oncocytoma." American Journal of Clinical Pathology 121, no. 6 (2004): 878-883.
• Park, J. T., et al. "Notch3 Gene Amplification in Ovarian Cancer." Cancer Research 66, no. 12 (2006): 6312-6318.
• Park, J.-W., et al. "A New Strategy for the Diagnosis of MAGE-Expressing Cancers." Journal of Immunological Methods 266, no. 1-2 (2002): doi:10.1016/S0022-1759(02)00105-9. »
• Paul, R., et al. "Cadherin-6: A New Prognostic Marker for Renal Cell Carcinoma." The Journal of Urology 171, no. 1 (2004): 97-101.
• Pehlivan, M., et al. "Can Mycoplasma-Mediated Oncogenesis Be Responsible for Formation of Conventional Renal Cell Carcinoma?" Urology 65, no. 2 (2005): 411-414.
• Pelosi, G., et al. "CD117 Immunoreactivity in Stage I Adenocarcinoma and Squamous Cell Carcinoma of the Lung: Relevance to Prognosis in a Subset of Adenocarcinoma Patients." Modern Pathology 17, no. 6 (2004): doi:10.1038/modpathol.3800110. »
• Pelosi, G., et al. "Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non-Small Cell Carcinomas of the Lung." The American Journal of Surgical Pathology 25, no. 3 (2001): 363-372.
• Pelosi, G., et al. "Independent Prognostic Value of Fascin Immunoreactivity in Stage I Non-Small Cell Lung Cancer." British Journal of Cancer 88, no. 4 (2003): doi:10.1038/sj.bjc.6600731. »
• Pelosi, G., et al. "Prognostic Implications of Neuroendocrine Differentiation and Hormone Production in Patients with Stage I Non-Small Cell Lung Carcinoma." Cancer 97, no. 10 (2003): 2487-2497.
• Perna, A. G., et al. "CD10 Is Expressed in Cutaneous Clear Cell Lesions of Different Histogenesis." Journal of Cutaneous Pathology 32, no. 5 (2005): 348-351.
• Petit, A., et al. "KIT Expression in Chromophobe Renal Cell Carcinoma: Comparative Immunohistochemical Analysis of KIT Expression in Different Renal Cell Neoplasms." American Journal of Surgical Pathology 28, no. 5 (2004): 676-678.
• Popović Hadzija, M., et al. "Infrequent Alteration of the DPC4 Tumor Suppressor Gene in Renal Cell Carcinoma." Urological Research 32, no. 3 (2004): 229-235.
• Porembska, Z., et al. "Arginase in Patients with Breast Cancer." Clinica Chimica Acta 328, no. 1-2 (2003): doi:10.1016/S0009-8981(02)00391-1. »
• Qin, W., et al. "Nipple Aspirate Fluid Expression of Urokinase-Type Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Urokinase-Type Plasminogen Activator Receptor Predicts Breast Cancer Diagnosis and Advanced Disease." Annals of Surgical Oncology 10, no. 8 (2003): doi:10.1245/ASO.2003.03.518. »
• Ramaiah, S. K. "A Toxicologist Guide to the Diagnostic Interpretation of Hepatic Biochemical Parameters." Food and Chemical Toxicology 45, no. 9 (2007): 1551-1557.
• Rao, P. N., et al. "Elevation of Serum Riboflavin Carrier Protein in Breast Cancer." Cancer Epidemiology, Biomarkers & Prevention 8, no. 11 (1999): 985-990.
• Reinholz, M. M., et al. "Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer." Clinical Cancer Research 11, no. 10 (2005): doi:10.1158/1078-0432.CCR-04-1483. »
• Rice, T. W., et al. "Expression of Blood Group Antigen A by Stage I Non–Small Cell Lung Carcinomas." The Annals of Thoracic Surgery 59, no. 3 (1995): 568-572.
• Rochefort, H. "Oestrogen- and Anti-Oestrogen-Regulated Genes in Human Breast Cancer." Ciba Foundation Symposium 191 (1995): 254-265.
• Romieu-Mourez, R., et al. "Roles of IKK Kinases and Protein Kinase CK2 in Activation of Nuclear Factor-kappaB in Breast Cancer." Cancer Research 61, no. 9 (2001): 3810-3818.
• Rosen, D. G., et al. "Expression of the Tumor Suppressor Gene ARHI in Epithelial Ovarian Cancer Is Associated with Increased Expression of p21^WAF1/CIP1 and Prolonged Progression-Free Survival." Clinical Cancer Research 10, no. 19 (2004): doi:10.1158/1078-0432.CCR-04-0698. »
• Roy, B. C., et al. "Pathological Characterization of Kank in Renal Cell Carcinoma." Experimental and Molecular Pathology 78, no. 1 (2005): 41-48.
• Roy, S. "Basaloid Squamous Cell Carcinoma of the Lung." Pulmonary Basaloid Squamous Cell Carcinoma. »
• Rui, Z., et al. "Use of Serological Proteomic Methods to Find Biomarkers Associated with Breast Cancer." Proteomics 3, no. 4 (2003): 433-439.
• Rundle, A., et al. "Association between the Ras p21 Oncoprotein in Blood Samples and Breast Cancer." Cancer Letters 185, no. 1 (2002): 71-78.
• Rusch, V. W., et al. "Molecular Markers Help Characterize Neuroendocrine Lung Tumors. Discussion." The Annals of Thoracic Surgery 62, no. 3 (1996): 798-810.
• Sakakura, C., et al. "Overexpression of Dopa Decarboxylase in Peritoneal Dissemination of Gastric Cancer and Its Potential as a Novel Marker for the Detection of Peritoneal Micrometastases with Real-Time RT-PCR." British Journal of Cancer 90, no. 3 (2004): 665-671.
• Sakurai, K., et al. "Study of Indoleamine 2,3-Dioxygenase Expression in Patients of Esophageal Squamous Cell Carcinoma." Gan To Kagaku Ryoho [Cancer and Chemotherapy] 31, no. 11 (2004): 1780-1782.
• Santen, R. J., et al. "The Role of Mitogen-Activated Protein (MAP) Kinase in Breast Cancer." The Journal of Steroid Biochemistry and Molecular Biology 80, no. 2 (2002): 239-256.
• Sauter, E. R., et al. "Prostate-Specific Antigen Expression in Nipple Aspirate Fluid Is Associated with Advanced Breast Cancer." Cancer Detection and Prevention 28, no. 1 (2004): doi:10.1016/j.cdp.2003.11.003. »
• Selvaggi, G., et al. "HER-2/neu Overexpression in Patients with Radically Resected Non-Small Cell Lung Carcinoma: Impact on Long-Term Survival." Cancer 94, no. 10 (2002): 2669-2674.
• Seo, J.-H., et al. "Follow-up Study of Peripheral Blood Carcinoembryonic Antigen mRNA Using Reverse Transcription-Polymerase Chain Reaction as an Early Marker of Clinical Recurrence in Patients with Curatively Resected Gastric Cancer." American Journal of Clinical Oncology 28, no. 1 (2005): 24-29.
• Shadeo, A., et al. "Comprehensive Serial Analysis of Gene Expression of the Cervical Transcriptome." BMC Genomics 8, no. 142 (2006): doi:10.1186/1471-2164-8-142. »
• Shah, L., et al. "Expression of Syndecan-1 and Expression of Epidermal Growth Factor Receptor Are Associated with Survival in Patients with Nonsmall Cell Lung Carcinoma." Cancer 101, no. 7 (2004): 1632-1638.
• Sheehan, M. and P. Haythorn. "Predictive Values of Various Liver Function Tests with Respect to the Diagnosis of Liver Disease." Clinical Biochemistry 12, no. 6 (1979): 262-263.
• Shen, Q. and P. H. Brown. "Novel Agents for the Prevention of Breast Cancer: Targeting Transcription Factors and Signal Transduction Pathways." Journal of Mammary Gland Biology and Neoplasia 8, no. 1 (2003): 45-73.
• Shen, S. S., et al. "Kidney-Specific Cadherin, a Specific Marker for the Distal Portion of the Nephron and Related Renal Neoplasms." Modern Pathology 18, no. 7 (2005): 933-940.
• Shieh, D. B., et al. "Mitochondrial DNA 4,977-bp Deletion in Paired Oral Cancer and Precancerous Lesions Revealed by Laser Microdissection and Real-Time Quantitative PCR." Annals of the New York Academy of Sciences 1011 (2004): 154-167.
• Shiga, Y., et al. "Case of α-Fetoprotein-Producing Transitional Cell Carcinoma of the Renal Pelvis." International Journal of Urology 11, no. 2 (2004): 117-118.
• Shulin, W., et al. "hnRNP B1 Protein May Be a Possible Prognostic Factor in Squamous Cell Carcinoma of the Lung." Lung Cancer 41, no. 2 (2003): 179-186.
• Sidhom, G. and M. Imam. "Evaluation of Serum Laminin as a Tumor Marker in Breast Cancer." International Journal of Clinical & Laboratory Research 29, no. 1 (1999): doi:10.1007/s005990050058. »
• Silva, E. G., et al. "Elevated Luteinizing Hormone in Serum, Breast Cancer Tissue, and Normal Breast Tissue from Breast Cancer Patients." Breast Cancer Research and Treatment 76, no. 2 (2002): 125-130.
• Simon-Kayser, B., et al. "Molecular Cloning and Characterization of FBXO47, a Novel Gene Containing an F-Box Domain, Located in the 17q12 Band Deleted in Papillary Renal Cell Carcinoma." Genes, Chromosomes & Cancer 43, no. 1 (2005): 83-94.
• Sjöström, J., et al. "Predictive Value of p53, mdm-2, p21, and mib-1 for Chemotherapy Response in Advanced Breast Cancer." Clinical Cancer Research 6, no. 8 (2000): 3103-3110.
• Skates, S. J., et al. "Preoperative Sensitivity and Specificity for Early-Stage Ovarian Cancer when Combining Cancer Antigen CA-125II, CA 15-3, CA 72-4, and Macrophage Colony-Stimulating Factor Using Mixtures of Multivariate Normal Distributions." Journal of Clinical Oncology 22, no. 20 (2004): 4059-4066.
• Sonoda, K., et al. "Biologic Significance of Receptor-Binding Cancer Antigen Expressed on SiSo Cells (RCAS1) as a Pivotal Regulator of Tumor Growth through Angiogenesis in Human Uterine Cancer." Cancer 110, no. 9 (2007): 1979-1990.
• Sorak, M., et al. "Relationship of Serum Levels of Tumor Markers with Tissue Expression of Gene Products in Ovarian Carcinoma." Journal of B.U.ON. 12, no. 1 (2007): 99-104.
• Soria, J.-S., et al. "Molecular Detection of Telomerase-Positive Circulating Epithelial Cells in Metastatic Breast Cancer Patients." Clinical Cancer Research 5, no. 5 (1999): 972-975.
• Soyupak, B., et al. "CA9 Expression as a Prognostic Factor in Renal Clear Cell Carcinoma." Urologia Internationalis 74, no. 1 (2005): 68-73.
• Srivastava, M., et al. "Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients." Clinical Cancer Research 10, no. 7 (2004): doi:10.1158/1078-0432.CCR-03-0278. »
• Stathopoulou, A., et al. "Real-Time Quantification of CK-19 mRNA-Positive Cells in Peripheral Blood of Breast Cancer Patients Using the Lightcycler System." Clinical Cancer Research 9, no. 14 (2003): 5145-5151.
• Stoyanova, R., et al. "Altered Gene Expression in Phenotypically Normal Renal Cells from Carriers of Tumor Suppressor Gene Mutations." Cancer Biology & Therapy 3, no. 12 (2004): 1313-1321.
• Straughn, J. M. Jr., et al. "Anti-Tumor Activity of TRA-8 Anti-Death Receptor 5 (DR5) Monoclonal Antibody in Combination with Chemotherapy and Radiation Therapy in a Cervical Cancer Model." Gynecologic Oncology 101, no. 1 (2006): doi:10.1016/j.ygyno.2005.09.053. »
• Struckmann, K. "Impaired Expression of the Cell Cycle Regulator BTG2 Is Common in Clear Cell Renal Cell Carcinoma." Cancer Research 64, no. 5 (2004): 1632-1638.
• Suefuji, Y., et al. "Expression of SART3 Antigen and Induction of CTLs by SART3-Derived Peptides in Breast Cancer Patients." British Journal of Cancer 84, no. 7 (2001): doi:10.1054/bjoc.2000.1690. »
• Sun, M., et al. "Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, Activated in Breast Cancer, Regulates and Is Induced by Estrogen Receptor α (ERα) via Interaction between ERα and PI3K." Cancer Research 61, no. 16 (2001): 5985-5991.
• Sutphen, R., et al. "Lysophospholipids Are Potential Biomarkers of Ovarian Cancer." Cancer Epidemiology, Biomarkers & Prevention 13, no. 7 (2004): 1185-1191.
• Taga, S., et al. "Prognostic Value of the Immunohistochemical Detection of p16INK4 Expression in Non-Small Cell Lung Carcinoma." Cancer 80, no. 3 (1997): 389-395.
• Takahashi, M., et al. "Altered Expression of Members of the IGF-Axis in Clear Cell Renal Cell Carcinoma." International Journal of Oncology 26, no. 4 (2005): 923-831.
• Takahashi, M., et al. "Gene Expression Profiling of Clear Cell Renal Cell Carcinoma: Gene Identification and Prognostic Classification." Proceedings of the National Academy of Sciences of the United States of America 98, no. 17 (2001): doi:10.1073/pnas.171209998. »
• Tamura, A., et al. "Prognostic Significance of Thrombomodulin Expression and Vascular Invasion in Stage I Squamous Cell Carcinoma of the Lung." Lung Cancer 34, no. 3 (2001): 375-382.
• Tanaka, E., et al. "The Clinical Significance of Aurora-A/STK15/BTAK Expression in Human Esophageal Squamous Cell Carcinoma." Clinical Cancer Research 11, no. 5 (2005): doi:10.1158/1078-0432.CCR-04-1627. »
• Tanaka, N., et al. "pRb2/p130 Protein Expression Is Correlated with Clinicopathologic Findings in Patients with Oral Squamous Cell Carcinoma." Cancer 92, no. 8 (2001): doi:10.1002/1097-0142(20011015)92:8<2117::AID-CNCR1553>3.0.CO;2-O. »
• Tang, H. J., et al. "A Small Molecule Compound Inhibits AKT Pathway in Ovarian Cancer Cell Lines." Gynecologic Oncology 100, no. 2 (2006): 308-317.
• Terashi, T., et al. "Decreased Expression of Osteopontin Is Related to Tumor Aggressiveness and Clinical Outcome of Intrahepatic Cholangiocarcinoma." Liver International 24, no. 1 (2004): 38-45.
• Terashita, Y., et al. "Excision Repair Cross Complementing 3 Expression Is Involved In Patient Prognosis and Tumor Progression in Esophageal Cancer." Oncology Reports 12, no. 4 (2004): 827-831.
• Theocharis, S., et al. "Expression of Peroxisome Proliferator Activated Receptor-Gamma in Non-Small Cell Lung Carcinoma: Correlation with Gistological Type and Grade." Lung Cancer 36, no. 3 (2002): 249-255.
• Thompson, R. H., et al. "Costimulatory B7-H1 in Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target." Proceedings of the National Academy of Sciences of the United States of America 101, no. 49 (2004): doi:10.1073/pnas.0406351101. »
• Tobioka, H., et al. "Expression of Occludin, a Tight-Junction-Associated Protein, in Human Lung Carcinomas." Virchows Archiv 445, no. 5 (2004): 472-476.
• Trougakos, I. P. and E. S. Gonos. "Clusterin/Apolipoprotein J in Human Aging and Cancer." The International Journal of Biochemistry & Cell Biology 34, no. 11 (2002): doi:10.1016/S1357-2725(02)00041-9. »
• Urban, G., et al. "Identification of an Estrogen-Inducible Phosphatase (PP5) that Converts MCF-7 Human Breast Carcinoma Cells into an Estrogen-Independent Phenotype when Expressed Constitutively." The Journal of Biological Chemistry 276, no. 29 (2001): 27638-27646.
• Vázquez-Ramírez, F. J., et al. "P-Glycoprotein, Metallothionein and NM23 Protein Expressions in Breast Carcinoma." Pathology, Research & Practice 196, no. 8 (2000): 553-559.
• Verma, A., et al. "MEMD/ALCAM: A Potential Marker for Tumor Invasion and Nodal Metastasis in Esophageal Squamous Cell Carcinoma." Oncology 68, no. 4-6 (2005): 462-470.
• Viacava, P., A. G. Naccarato, and G. Bevilacqua. "Different Proliferative Patterns Characterize Different Preinvasive Breast Lesions." The Journal of Pathology 188, no. 3 (1999): doi:10.1002/(SICI)1096-9896(199907)188:3<245::AID-PATH353>3.0.CO;2-6. »
• Vocke, C. D., et al. "High Frequency of Somatic Frameshift BHD Gene Mutations in Birt-Hogg-Dubé-Associated Renal Tumors." Journal of the National Cancer Institute 97, no. 12 (2005): 931-935.
• Volm, M., J. Mattern, and R. Koomägi. "Association of Telomerase Expression with Successful Heterotransplantation of Lung Cancer." International Journal of Oncology 16, no. 1 (2000): 31-35.
• Wamunyokoli, F. W., et al. "Expression Profiling of Mucinous Tumors of the Ovary Identifies Genes of Clinicopathologic Importance." Clinical Cancer Research 12, no. 3 (2006): 690-700.
• Wang, J. Y., et al. "Alterations of APC, c-met, and p53 Genes in Tumor Tissue and Serum of Patients with Gastric Cancers." The Journal of Surgical Research 120, no. 2 (2004): 242-248.
• Wang, J. Y., et al. "Diagnostic Application of Detecting AgNOR in Peripheral Blood T Lymphocyte in Patients with Esophageal Carcinoma." Ai Zheng [Chinese Journal of Cancer] 23, no. 5 (2004): 577-580.
• Wang, Q., et al. "Anti-Apoptotic Role of BARF1 in Gastric Cancer Cells." Cancer Letters 238, no. 1 (2006): 90-103.
• Wang, Z., et al. "Detection of Peritoneal Micrometastasis by Reverse Transcriptase-Polymerase Chain Reaction for Heparanase mRNA and Cytology in Peritoneal Wash Samples." Journal of Surgical Oncology 90, no. 2 (2005): 59-65.
• Wang, Z. N., et al. "Expression of Survivin in Primary and Metastatic Gastric Cancer Cells Obtained by Laser Capture Microdissection." World Journal of Gastroenterology 10, no. 21 (2004): 3094-3098.
• Wascher, R. A., et al. "Stanniocalcin-1: A Novel Molecular Blood and Bone Marrow Marker for Human Breast Cancer." Clinical Cancer Research 9, no. 14 (2003): 1427-1435.
• Whitehurst, M. M., et al. "Evaluation of the BT-1 Serum Assay for Breast Cancer." Human Antibodies 9, no. 3 (1999): 155-160.
• Whitney, J. F., et al. "Transferrin Receptor Expression in Non-Small Cell Lung Cancer: Histopathologic and Clinical Correlates." Cancer 76, no. 1 (1995): 20-25.
• Wollmann, W., et al. "The Macrophage Inhibitory Cytokine Integrates AKT/PKB and MAP Kinase Signaling Pathways in Breast Cancer Cells." Carcinogenesis 26, no. 5 (2005): doi:10.1093/carcin/bgi031. »
• Wooster, R., et al. "Identification of the Breast Cancer Susceptibility Gene BRCA2." Nature 378, no. 6559 (1995): 789-792.
• Wrighton, S. A. and J. C. Stevens. "The Human Hepatic Cytochromes P450 Involved in Drug Metabolism." Critical Reviews in Toxicology 22, no. 1 (1992): 1-21.
• Yamada, Y., et al. "Elevated Transcript Level of Hyaluronan Synthase1 Gene Correlates with Poor Prognosis of Human Colon Cancer." Clinical and Experimental Metastasis 21, no. 1 (2004): doi:10.1023/B:CLIN.0000017203.71293.e0. »
• Yamashita, J., et al. "High Levels of Hepatocyte Growth Factor/Scatter Factor in Diffuse-Type Bronchioloalveolar Cell Carcinoma." Cancer 83, no. 10 (1998): 2091-2098.
• Yang, R. Z., et al. "cDNA Cloning, Genomic Structure, Chromosomal Mapping, and Functional Expression of a Novel Human Alanine Aminotransferase." Genomics 79, no. 3 (2002): 445-450.
• Yang, X., et al. "Overexpression of Anti-Apoptotic Gene BAG-1 in Human Cervical Cancer." Experimental Cell Research 247, no. 1 (1999): doi:10.1006/excr.1998.4349. »
• Yano, T., et al. "Hypermethylation of the CpG Island of Connexin 32, a Candidate Tumor Suppressor Gene in Renal Cell Carcinomas from Hemodialysis Patients." Cancer Letters 208, no. 2 (2004): doi:10.1016/j.canlet.2003.11.029. »
• Yi, E. S., et al. "High c-erbB-3 Protein Expression Is Associated with Shorter Survival in Advanced Non-Small Cell Lung Carcinomas." Modern Pathology 10, no. 2 (1997): 143-148.
• Yoo, S.-H., et al. "Expression of Caveolin-1 Is Associated with Poor Prognosis of Patients with Squamous Cell Carcinoma of the Lung." Lung Cancer 42, no. 2 (2003): doi:10.1016/S0169-5002(03)00287-3. »
• Yoshinari, K., et al. "Human Monoclonal Antibody 28K29 Highly Reactive with Lung Adenocarcinomas of All Grades of Differentiation and with Large Cell Carcinomas." Lung Cancer 25, no. 2 (1999): doi:10.1016/S0169-5002(99)00040-9. »
• Yousef, G. M., et al. "A Potential Novel Serum Biomarker for Breast and Ovarian Cancer." Cancer Research 63, no. 14 (2003): 3958-3965.
• Yu, F., et al. "Expression of Focal Adhesion Kinase in Laryngeal Carcinoma." Lin Chuang Er Bi Yan Hou Ke Za Zhi [Journal of Clinical Otorhinolaryngology] 18, no. 3 (2004): 149-151.
• Zhang, F., et al. "Thymidine Kinase 1 Immunoassay: A Potential Marker for Breast Cancer." Cancer Detection and Prevention 25, no. 1 (2001): 8-15.
• Zhang, Y. L., et al. "Detection of CK20mRNA in Peripheral Blood of Pancreatic Cancer and Its Clinical Significance." World Journal of Gastroenterology 11, no. 7 (2005): 1023-1027.
• Zhoi, X., et al. "Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers." Clinical Cancer Research 10, no. 20 (2004): doi:10.1158/1078-0432.CCR-04-0112. »
• Zhou, Y., et al. "The NFkappaB Pathway and Endocrine-Resistant Breast Cancer." Endocrine-Related Cancer 12, supplement 1 (2005): S37-S46.
• Zollner, G., et al. "Role of Nuclear Receptors in the Adaptive Response to Bile Acids and Cholestasis: Pathogenetic and Therapeutic Considerations." Molecular Pharmaceutics 3, no. 3 (2006): 231-251.
• Zubakov, D., Z. Stupar, and G. Kovacs. "Differential Expression of a New Isoform of DLG2 in Renal Oncocytoma." BMC Cancer 6, no. 106 (2006): doi:10.1186/1471-2407-6-106. »
• Zurawski, V. R. Jr., et al. "Serum CA 125 Levels in a Group of Nonhospitalized Women: Relevance for the Early Detection of Ovarian Cancer." Obstetrics and Gynecology 69, no. 4 (1984): 606-611.
• Zweemer, R. P., et al. "Accumulation of p53 Protein Is Frequent in Ovarian Cancers Associated with BRCA1 and BRCA2 Germline Mutations." Journal of Clinical Pathology 52, no. 5 (1999): doi:10.1136/jcp.52.5.372. »

Note: This list is intended as a guide to sources and further information. The inclusion of an item in this list does not necessarily mean that its content was used as the basis for any specific Wolfram|Alpha result. Requests by researchers for detailed information on the sources for individual results can be directed here »